Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments

  • Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance RD of new treatments against NTDs and malaria over five years
  • Commitment includes USD 100 million to advance RD for Chagas disease, leishmaniasis, dengue and cryptosporidiosis, and USD 150 million for......
    . .
    Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Thursday, 23 June
Share |